• USask statement on 2024-25 federal budget

    The University of Saskatchewan applauds the 2024-25 federal budget’s strong support for key areas of post-secondary education and research.

  • USask’s VIDO selected to join DIANA innovation accelerator

    VIDO has been selected to join the North Atlantic Treaty Organization’s (NATO) Defence Innovation Accelerator for the North Atlantic (DIANA) program. VIDO is one of 13 new Canadian test centres chosen to be part of the network.

  • VIDO scientists receive CIHR funding to support research on high impact infectious diseases

    New awards from the Canadian Institutes of Health Research Project Grant from the Fall 2023 competition will support VIDO scientists as they try to solve highly pathogenic coronaviruses, tuberculosis, and influenza.

  • VIDO awarded >$1million to develop innovative solutions for Saskatchewan’s agriculture industry

    Three VIDO scientists were awarded >$1 million in total from the Saskatchewan Ministry of Agriculture’s Agriculture Development Fund (ADF).

  • VIDO awarded U.S. contract for its Vaccine Development Centre

    VIDO has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the United States’ National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

  • VIDO’s first Animal Health Summit brings animal health stakeholders together to prepare for foot and mouth disease

    On August 24th, VIDO hosted a half-day summit on foot-and-mouth disease (FMD). Our biannual Animal Health Summit will bring together stakeholders to facilitate knowledge exchange and preparedness on a topic of interest.

  • VIDO and Pirbright expand collaboration to advance vaccine manufacturing

    VIDO has signed a memorandum of understanding (MOU) with the Centre for Veterinary Vaccine Innovation and Manufacturing at the Pirbright Institute in the UK. The MOU allows for expanded animal health collaborations and training.

  • USask’s VIDO selected for CEPI’s international research network

    VIDO has signed an agreement to join the Coalition for Epidemic Preparedness Innovations’ (CEPI) preclinical research network—the only organization in Canada and the ninth in the world selected for this research network to date.

  • VIDO receives significant CIHR support for research into emerging coronaviruses

    VIDO scientists have received support from the Canadian Institutes of Health Research’s Spring 2023 competition.

  • New funding to advance Canada’s beef sector

    Dr. Antonio Facciuolo has new support to develop a vaccine against Johne’s disease—a chronic intestinal disease of cattle that is significant to both the beef and dairy industry.